| |
2011 PRESS RELEASES |
|
December 07 - 2011 |
Italian Laboratory Expands ProtoKinetix' Market for AAGP™
|
READ |
September 21 - 2011 |
ProtoKinetix Receives Excellent Results from the University of British Columbia Eye Inflammation Study
|
READ |
August 18 - 2011 |
ProtoKinetix Launches Sales of AAGP™ as a Tool to Protect Cells in Research
|
READ |
July 25 - 2011 |
The University of British Columbia Studies the Development of ProtoKinetix' AAGP™ Anti-Inflammatory for the $20-Billion Eye Treatment Market
|
READ |
May 04 - 2011 |
ProtoKinetix President and CEO to be Interviewed Live
|
READ |
April 27 - 2011 |
ProtoKinetix Forms Joint Venture Partnership to Launch a Dermatitis Therapeutic Product for the Skin Care Industry
|
READ |
March 16 - 2011 |
ProtoKinetix AAGP™ Dramatically Increase Recovery Rate of Cryopreserved and Refrigerated Stem Cells
|
READ |
March 08 - 2011 |
ProtoKinetix' Lead Investigator and Scientific Advisor published in Nature
|
READ |
March 01 - 2011 |
ProtoKinetix Funds Independent Confirmatory Trials |
READ |
|
|
|
| |
2010 PRESS RELEASES |
|
September 23 - 2010 |
ProtoKinetix in Partnership Discussions with Diabetes Specific Foundations and Research Organizations |
READ |
March 12 - 2010 |
ProtoKinetix, Inc.(PKTX) .10 a share Target price .20
POSTED BY $ MAD MONEY FUND |
READ |
January 25 - 2010 |
ProtoKinetix’ Childhood Diabetes Initiative Strengthened by Addition to Scientific Advisory Board |
READ |
January 14 - 2010 |
Defeat Diabetes Foundation Co-Founder Joins ProtoKinetix' Advisory Board |
|
January 12 - 2010 |
ProtoKinetix’ AAGP™ Shows Promise as a Tool in Diabetes Treatment / Cure |
|
| |
|
|
| |
2009 PRESS RELEASES |
|
|
|
|
September 24 - 2009 |
ProtoKinetix' Advisory Boards Launch Major Commericial Initiatives for It's AAGPs |
|
August 18 - 2009 |
Anti Oxidants to be Showcased at World Conference on Skin Aging |
|
July 22 - 2009 |
L'Oreal Independently Validates ProtoKinetix' AAGP™ Cosmetic Application |
|
February 19 - 2009 |
ProtoKinetix’ AAGP™ is Critical for Stem Cell Therapy |
|
January 15 - 2009 |
ProtoKinetix' Joint Venture to Produce Exclusive Combination
AAGP™ and Co-enzyme Q10 Skin/Health Care Product Line |
|
| |
|
|
| |
2008 PRESS RELEASES |
|
November 17 - 2008 |
ProtoKinetix Signs Collaboration with Multi-National Corporation |
|
November 10 - 2008 |
ProtoKinetix Receives Independent Confirmation of
AAGP Anti-Inflammatory Action |
|
October 28 - 2008 |
OTC Financial Network Issues Corporate Profile on ProtoKinetix Inc.
--Patented, Revolutionary Technology Shown to Increase Cellular Health-- |
|
October 14 - 2008 |
ProtoKinetix Partners with OTC Financial Network to Increase Shareholder Base |
|
September 03 - 2008 |
ProtoKinetix Contracted to Produce AAGP™ for New Product Launch |
|
July 31 - 2008 |
Prototype AAGP™ Derivative Expands ProtoKinetix’ Intellectual Property and Cell Survival Applications
|
|
|
Former Navy Surgeon General, Admiral Harold M. Koenig, M.D. Joins ProtoKinetix |
|
|
John S. Parker, M.D., Major General (Ret.) Appointed Chairman of ProtoKinetix' Science Advisory Board
|
|
|
ProtoKinetix to Open Washington, D.C. Office
|
|
|
ProtoKinetix Names Key Addition to Its Executive Management Team
|
|
|
Chairman of ProtoKinetix Business Advisory Board Outlines Priorities
|
|
|
Umbilical Cord Blood Industry Tests ProtoKinetix' AAGP(TM)
|
|
|
Edward D. Martin, M.D. Accepts Chair of ProtoKinetix' Business Advisory Board
|
|
| |
|
|
| |
2007 PRESS RELEASES |
|
| |
|
|
|
ProtoKinetix Targets Multi Billion Dollar Stem Cell Industry |
READ |
|
Significant Addition to ProtoKinetix’ Board of Directors |
READ |
|
ProtoKinetix Appoints Skin Care and Cosmetic Business Adviser |
READ |
|
Major Breakthrough for Blood Storage Using AAGP™ |
READ |
|
Refrigerated Stem Cells Survive 12 Times Longer with ProtoKinetix's AAGP(TM) |
READ |
|
ProtoKinetix’ AAGP™ Dramatically Increases Recovery Rate of Cryopreserved Stem Cells |
READ |
|
ProtoKinetix’ AAGP™ Improves Effectiveness of Diabetes Treatment |
READ |
|
ProtoKinetix Evaluates Results of Recent Stem Cell Storage Using AAGP™ |
READ |
|
ProtoKinetix Commences AGORACOM Google IR Program |
READ |
|
ProtoKinetix’ AAGP™ Preserves 100% Viable Stem Cells |
READ |
| |
|
|
| |
2006 PRESS RELEASES |
|
| |
|
|
|
ProtoKinetix’ AAGP™ Doubles Viability of Cryopreserved Stem Cells |
|
November 21 - 2006 |
Current Testing Strongly Supports NSAID Properties of AAGP™ |
|
November 14 - 2006 |
ProtoKinetix Discovers a Major New Market for AAGP™ |
|
October 17 - 2006 |
Anti-Aging Glycoprotein AAGP™ Protects and Repairs |
|
October 16 - 2006 |
ProtoKinetix’ AAGP™ Significantly Reduces Inflammation |
|
October 12 - 2006 |
European Scientific Community Recognizes Core Science Behind ProtoKinetix’ AAGP™ Family of Molecules |
|
September 12 - 2006 |
ProtoKinetix Takes Major Step Towards AAGP™ Commercialization |
|
August 8 - 2006 |
ProtoKinetix, Inc. Fast Tracks Medical Application for AAGP™ |
|
August 8 - 2006 |
ProtoKinetix AAGP™ Showcased at GECO47 |
|
July 21 - 2006 |
INSA Chooses AAGP™ to Present at Annual GECO Conference |
|
July 19 - 2006 |
ProtoKinetix’ AAGP™ Protects Cells While Preserving Normal Cell Function |
|
July 12 - 2006 |
ProtoKinetix Receives Definitive Confirmation of AAGP™ Preservative Qualities |
|
May 08 - 2006 |
ProtoKinetix Expands Its Family of AAGP™ Molecules |
|
April 20 - 2006 |
ProtoKinetix Featured in Equities Magazine |
|
February 15 - 2006 |
Exposure to ProtoKinetix’ AAGP™ Maintains Cell Integrity and Cell Function |
|
January 26 - 2006 |
ProtoKinetix’ AAGP™ Proves to be a Powerful Additive |
|
January 24 - 2006 |
ProtoKinetix’ AAGP™ Begins 2006 on a Very Positive Note |
|
January 10 - 2006 |
Dramatic AAGP™ Concentration Reductions Show Continued Skin Cell Preservation |
|
|
|
|
|
2005 PRESS RELEASES |
|
|
|
|
|
ProtoKinetix' Synthetic Antifreeze Glycoprotein is Now Trademarked as AAGP
|
|
|
Increased Concentrations of ProtoKinetix's Synthetic AFGP Dramatically Slows Aging Process on Skin Cells
|
|
|
AudioStocks.com Interviews Leading Executives
|
|
|
CEO of ProtoKinetix, Inc. Discusses Recent AFGP Results and Commercialization Strategy on AudioStocks.com
|
|
|
ProtoKinetix Receives Remarkable Results from Study Using Synthetic AFGP on Skin Cells
|
|
|
ProtoKinetix Commences Organ Preservation Trials
|
|
|
ProtoKinetix Announces Commercialization Strategy for AFGP
|
|
|
AudioStocks.com Interviews Leading Executives
|
|
|
Protokinetix, Inc. CEO Interview Available on AudioStocks.com
|
|
|
Higher Concentrations of ProtoKinetix's Synthetic AFGP Show Significant Increase in Heart Cell Survivability
|
|
|
Collaborative Agreement Reached with Premier Research Institution
|
|
|
Survival of Sensitive Heart Cells After Freezing Shows Promise for Increased Organ Shelf Life
|
|
|
Second Generation Synthetic AFGP Tests Stable and Safe
|
|
|
University of Rouen Laboratory Announces Completion Of Second Generation Synthetic AFGP
|
|
|
International Blood Services Groups Eager to Commence Testing on Synthetic AFGP
|
|
|
ProtoKinetix' Synthetic AFGP Dramatically Reduces Platelet Aggregation -- Clumping -- at Various Temperatures
|
|
|
ProtoKinetix: ProteoCell Laboratory Reports on Cell Survivability in the Presence of Synthetic AFGP
|
|
| |
|
|
| |
2004 PRESS RELEASES |
|
| |
|
|
|
Trial Results Are Significant Breakthrough For ProtoKinetix |
|
|
Georges Pompidou Hospital Reports Clear Labelling of Malignant Cells |
|
|
Jean-Charles Quirion, Ph.D Accepts Position on ProtoKinetix Scientific Advisory Board |
|
|
Preliminary Results |
|
|
Dr. Jean-Marie Dupuy Accepts Position on ProtoKinetix Board of Directors |
|
| |
|
|
| |
2003 PRESS RELEASES |
|
| |
|
|
|
ProtoKinetix Reaches Agreement on Research to Deliver Catalytic Antibody |
|
|
Dr. John Todd States How Validation Trials Will Fast Track Therapeutic Development |
|
|
ProtoKinetix Announces Independent Group of Validation Trials by European Hospital Georges Pompidou |
|
|
ProtoKinetix Announces Appointment of Dr. Ricardo Moro-Vidal to it's Scientific Advisor Board |
|
| |
|
|
| |
|
|
| |
|
|
